LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/19/2023
Back to search
Official data from USPTO
IPS STOCK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079296113Class
1, 5, 39, 42, 44
Filing
79296113
Registration
6481108
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/19/2023
Trademark type
Combined
Nice classes
1, 5, 39, 42, 44
Filing date
04/30/2020
Registration date
09/14/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2021
Last transaction
09/14/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
JP
Examiner
SAUNDERS, ANDREA DAWN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "IPS STOCK" inside a box on two lines with "I" in blue, "P" in red, "S" in green, and "STOCK" in black, on top of blue, green, and red diagonal bands, the color white in the drawing represents background or transparent area and is not part of the mark.
Holders and representatives
Holders
C. F. (pessoa física)
Representatives
Dawn Rudenko Holland & Knight LLP
Technical classification
Nice Classes
Class 1Class 5Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research and scientific purposes; stem cellsother than for medical or veterinary purposes; industrial chemicals; chemical test paperother than for medical purposes; cell culture reagents for laboratory use; cell culture media for scientific or research purposes; biological preparation for use in cell cultures other than for medical or veterinary use
Class 5
Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper being reagent paper for medical purposes; living cells for medical use; cells for medical use; tissues for medical usebiological tissue cultures for medical purposes
Class 39
Storage of frozen living cells; storage of biological tissuescells and stem cells; warehousing services for deposited articles
Class 42
Scientific research on stem cells; cell culture services for scientific and research purposesfor others; cytogenetic examination for research purposes; testingexaminationresearch and development in the field of cytology; testingexaminationresearch and development in the field of regenerative medicine; testingexaminationresearch and development of pharmaceuticals; clinical studies; medical laboratory services; providing quality assurance in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on medical research and testing related to stem cells; providing information related to research and development of pharmaceutical preparations; testingexamination and research of medical therapy methods and technologies; testingexamination and research of cosmetics and foods; design and development of computer hardware and computer software for use in the field of medical science; design and development of machinesapparatusinstruments and systems in the field of medical science; designdevelopment and maintenance of computer programs; testing and research on machinesapparatusinstruments in the field of medical science ; rental of laboratory apparatus and instruments
Class 44
Stem cell therapy services; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissuesblood and cells; medical treatment and diagnosis services in the nature of regenerative therapy by using a cell culture; cell culture bank services for medical transplantation; medical care; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis in the nature of regenerative therapy by regenerative medicine; medical cell therapy and diagnosis services in the nature of regenerative cell therapy; medical treatment and consulting services in the nature of regenerative cell therapy by cell preparations; preservation of human blood for stem cells; providing medical information and medical record analysis for use in medical treatment; clinical medical examination services; providing health care services; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus and instruments
Publications
History of USPTO decisions and trademark events.
28 publications found
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/05/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/01/2022
FIMP
FINAL DISPOSITION PROCESSED
02/28/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/14/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/14/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/29/2021
PUBO
PUBLISHED FOR OPPOSITION
06/29/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/14/2021
RFNT
REFUSAL PROCESSED BY IB
12/07/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/16/2020
RFRR
REFUSAL PROCESSED BY MPU
11/16/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/27/2020
CNRT
NON-FINAL ACTION WRITTEN
10/26/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2020
DOCK
ASSIGNED TO EXAMINER
10/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/15/2020
Continuous trademark protection
Get notified about every new filing that threatens IPS STOCK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.